|
Asthma Drug Relva Approved In Europe, Japan, But Not The United States
The Inquisitr The United States has already approved the new Asthma drug but it's marketed as Breo in the United States. But US doctors are only allowed to prescribe Breo for chronic obstructive pulmonary disease (COPD) while Europe is recommending the new drug for … Relvar Ellipta Approved in Japan for Treatment of Asthma GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma … Double asthma approval in Japan lifts SkyePharma |
View full post on asthma – Google News